Follow-up investigations on clinical manifestations after filariasis eradication by diethylcarbamazine medicated common salt on Kinmen (Quemoy) Islands, Republic of China.
Identifieur interne : 00B654 ( Ncbi/Checkpoint ); précédent : 00B653; suivant : 00B655Follow-up investigations on clinical manifestations after filariasis eradication by diethylcarbamazine medicated common salt on Kinmen (Quemoy) Islands, Republic of China.
Auteurs : P C Fan [République populaire de Chine] ; H W Peng ; C C ChenSource :
- The Journal of tropical medicine and hygiene [ 0022-5304 ] ; 1995.
Descripteurs français
- KwdFr :
- Adulte, Adulte d'âge moyen, Animaux, Association de médicaments, Chlorure de sodium (administration et posologie), Chlorure de sodium (usage thérapeutique), Collecte de données, Diéthylcarbamazine (administration et posologie), Diéthylcarbamazine (usage thérapeutique), Femelle, Filaricides (administration et posologie), Filaricides (usage thérapeutique), Filariose lymphatique (traitement médicamenteux), Filariose lymphatique (épidémiologie), Filariose lymphatique (étiologie), Humains, Maladie aigüe, Maladie chronique, Mâle, Porteur sain (traitement médicamenteux), Porteur sain (épidémiologie), Sujet âgé, Sujet âgé de 80 ans ou plus, Taïwan (épidémiologie), Wuchereria bancrofti, Études de suivi.
- MESH :
- administration et posologie : Chlorure de sodium, Diéthylcarbamazine, Filaricides.
- traitement médicamenteux : Filariose lymphatique, Porteur sain.
- usage thérapeutique : Chlorure de sodium, Diéthylcarbamazine, Filaricides.
- épidémiologie : Filariose lymphatique, Porteur sain, Taïwan.
- étiologie : Filariose lymphatique.
- Adulte, Adulte d'âge moyen, Animaux, Association de médicaments, Collecte de données, Femelle, Humains, Maladie aigüe, Maladie chronique, Mâle, Sujet âgé, Sujet âgé de 80 ans ou plus, Wuchereria bancrofti, Études de suivi.
- Wicri :
- geographic : Taïwan.
English descriptors
- KwdEn :
- Acute Disease, Adult, Aged, Aged, 80 and over, Animals, Carrier State (drug therapy), Carrier State (epidemiology), Chronic Disease, Data Collection, Diethylcarbamazine (administration & dosage), Diethylcarbamazine (therapeutic use), Drug Therapy, Combination, Elephantiasis, Filarial (drug therapy), Elephantiasis, Filarial (epidemiology), Elephantiasis, Filarial (etiology), Female, Filaricides (administration & dosage), Filaricides (therapeutic use), Follow-Up Studies, Humans, Male, Middle Aged, Sodium Chloride (administration & dosage), Sodium Chloride (therapeutic use), Taiwan (epidemiology), Wuchereria bancrofti.
- MESH :
- chemical , administration & dosage : Diethylcarbamazine, Filaricides, Sodium Chloride.
- geographic , epidemiology : Taiwan.
- drug therapy : Carrier State, Elephantiasis, Filarial.
- epidemiology : Carrier State, Elephantiasis, Filarial.
- etiology : Elephantiasis, Filarial.
- chemical , therapeutic use : Diethylcarbamazine, Filaricides, Sodium Chloride.
- Acute Disease, Adult, Aged, Aged, 80 and over, Animals, Chronic Disease, Data Collection, Drug Therapy, Combination, Female, Follow-Up Studies, Humans, Male, Middle Aged, Wuchereria bancrofti.
Abstract
From May to December 1993, a house-by-house survey was conducted on the changes in clinical manifestations of filariasis among 814 pre-control mf carriers in 88 villages of five towns/districts on Kinmen Islands. Four hundred and sixteen (51%) pre-control mf carriers were examined physically with history taking. The rates of disappearance, improvement, no change, aggravation, and new occurrence were 72% (229), 6% (26), 14% (59), 6% (24) and 2% (8), respectively. The rates of disappearance and improvement were higher for the acute than for the chronic manifestations. However, these rates were also high for hydrocele and chyluria. These findings indicate that the acute manifestations disappear or greatly improve after filariasis eradication by a low dose of DEC medicated salt for a period of 6 months. However, the chronic ones remain unchanged or even aggravated to become one of the more important public health problems.
PubMed: 8544232
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 005295
- to stream PubMed, to step Curation: 005295
- to stream PubMed, to step Checkpoint: 005295
- to stream Ncbi, to step Merge: 00B654
- to stream Ncbi, to step Curation: 00B654
Links to Exploration step
pubmed:8544232Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Follow-up investigations on clinical manifestations after filariasis eradication by diethylcarbamazine medicated common salt on Kinmen (Quemoy) Islands, Republic of China.</title><author><name sortKey="Fan, P C" sort="Fan, P C" uniqKey="Fan P" first="P C" last="Fan">P C Fan</name><affiliation wicri:level="1"><nlm:affiliation>Department of Parasitology, School of Medicine, National Yangming University, Taipei, Republic of China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Parasitology, School of Medicine, National Yangming University, Taipei</wicri:regionArea><wicri:noRegion>Taipei</wicri:noRegion></affiliation></author><author><name sortKey="Peng, H W" sort="Peng, H W" uniqKey="Peng H" first="H W" last="Peng">H W Peng</name></author><author><name sortKey="Chen, C C" sort="Chen, C C" uniqKey="Chen C" first="C C" last="Chen">C C Chen</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="1995">1995</date><idno type="RBID">pubmed:8544232</idno><idno type="pmid">8544232</idno><idno type="wicri:Area/PubMed/Corpus">005295</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">005295</idno><idno type="wicri:Area/PubMed/Curation">005295</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">005295</idno><idno type="wicri:Area/PubMed/Checkpoint">005295</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">005295</idno><idno type="wicri:Area/Ncbi/Merge">00B654</idno><idno type="wicri:Area/Ncbi/Curation">00B654</idno><idno type="wicri:Area/Ncbi/Checkpoint">00B654</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Follow-up investigations on clinical manifestations after filariasis eradication by diethylcarbamazine medicated common salt on Kinmen (Quemoy) Islands, Republic of China.</title><author><name sortKey="Fan, P C" sort="Fan, P C" uniqKey="Fan P" first="P C" last="Fan">P C Fan</name><affiliation wicri:level="1"><nlm:affiliation>Department of Parasitology, School of Medicine, National Yangming University, Taipei, Republic of China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Parasitology, School of Medicine, National Yangming University, Taipei</wicri:regionArea><wicri:noRegion>Taipei</wicri:noRegion></affiliation></author><author><name sortKey="Peng, H W" sort="Peng, H W" uniqKey="Peng H" first="H W" last="Peng">H W Peng</name></author><author><name sortKey="Chen, C C" sort="Chen, C C" uniqKey="Chen C" first="C C" last="Chen">C C Chen</name></author></analytic><series><title level="j">The Journal of tropical medicine and hygiene</title><idno type="ISSN">0022-5304</idno><imprint><date when="1995" type="published">1995</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Acute Disease</term><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Animals</term><term>Carrier State (drug therapy)</term><term>Carrier State (epidemiology)</term><term>Chronic Disease</term><term>Data Collection</term><term>Diethylcarbamazine (administration & dosage)</term><term>Diethylcarbamazine (therapeutic use)</term><term>Drug Therapy, Combination</term><term>Elephantiasis, Filarial (drug therapy)</term><term>Elephantiasis, Filarial (epidemiology)</term><term>Elephantiasis, Filarial (etiology)</term><term>Female</term><term>Filaricides (administration & dosage)</term><term>Filaricides (therapeutic use)</term><term>Follow-Up Studies</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Sodium Chloride (administration & dosage)</term><term>Sodium Chloride (therapeutic use)</term><term>Taiwan (epidemiology)</term><term>Wuchereria bancrofti</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Animaux</term><term>Association de médicaments</term><term>Chlorure de sodium (administration et posologie)</term><term>Chlorure de sodium (usage thérapeutique)</term><term>Collecte de données</term><term>Diéthylcarbamazine (administration et posologie)</term><term>Diéthylcarbamazine (usage thérapeutique)</term><term>Femelle</term><term>Filaricides (administration et posologie)</term><term>Filaricides (usage thérapeutique)</term><term>Filariose lymphatique (traitement médicamenteux)</term><term>Filariose lymphatique (épidémiologie)</term><term>Filariose lymphatique (étiologie)</term><term>Humains</term><term>Maladie aigüe</term><term>Maladie chronique</term><term>Mâle</term><term>Porteur sain (traitement médicamenteux)</term><term>Porteur sain (épidémiologie)</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Taïwan (épidémiologie)</term><term>Wuchereria bancrofti</term><term>Études de suivi</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Diethylcarbamazine</term><term>Filaricides</term><term>Sodium Chloride</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Taiwan</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Chlorure de sodium</term><term>Diéthylcarbamazine</term><term>Filaricides</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Carrier State</term><term>Elephantiasis, Filarial</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Carrier State</term><term>Elephantiasis, Filarial</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Elephantiasis, Filarial</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Diethylcarbamazine</term><term>Filaricides</term><term>Sodium Chloride</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Filariose lymphatique</term><term>Porteur sain</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Chlorure de sodium</term><term>Diéthylcarbamazine</term><term>Filaricides</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Filariose lymphatique</term><term>Porteur sain</term><term>Taïwan</term></keywords><keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Filariose lymphatique</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Acute Disease</term><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Animals</term><term>Chronic Disease</term><term>Data Collection</term><term>Drug Therapy, Combination</term><term>Female</term><term>Follow-Up Studies</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Wuchereria bancrofti</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Animaux</term><term>Association de médicaments</term><term>Collecte de données</term><term>Femelle</term><term>Humains</term><term>Maladie aigüe</term><term>Maladie chronique</term><term>Mâle</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Wuchereria bancrofti</term><term>Études de suivi</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Taïwan</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">From May to December 1993, a house-by-house survey was conducted on the changes in clinical manifestations of filariasis among 814 pre-control mf carriers in 88 villages of five towns/districts on Kinmen Islands. Four hundred and sixteen (51%) pre-control mf carriers were examined physically with history taking. The rates of disappearance, improvement, no change, aggravation, and new occurrence were 72% (229), 6% (26), 14% (59), 6% (24) and 2% (8), respectively. The rates of disappearance and improvement were higher for the acute than for the chronic manifestations. However, these rates were also high for hydrocele and chyluria. These findings indicate that the acute manifestations disappear or greatly improve after filariasis eradication by a low dose of DEC medicated salt for a period of 6 months. However, the chronic ones remain unchanged or even aggravated to become one of the more important public health problems.</div></front></TEI><affiliations><list><country><li>République populaire de Chine</li></country></list><tree><noCountry><name sortKey="Chen, C C" sort="Chen, C C" uniqKey="Chen C" first="C C" last="Chen">C C Chen</name><name sortKey="Peng, H W" sort="Peng, H W" uniqKey="Peng H" first="H W" last="Peng">H W Peng</name></noCountry><country name="République populaire de Chine"><noRegion><name sortKey="Fan, P C" sort="Fan, P C" uniqKey="Fan P" first="P C" last="Fan">P C Fan</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Ncbi/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 00B654 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd -nk 00B654 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Ncbi
|étape= Checkpoint
|type= RBID
|clé= pubmed:8544232
|texte= Follow-up investigations on clinical manifestations after filariasis eradication by diethylcarbamazine medicated common salt on Kinmen (Quemoy) Islands, Republic of China.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/RBID.i -Sk "pubmed:8544232" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |